| BHC-12 |
A |
09:00 AM - 09:10 AM |
MULTICOMPONENT HAEMOSTATIC WOUND HEALING MATRIX |
RENJITH P NAIR |
| BHC-49 |
A |
09:10 AM - 09:20 AM |
THE CLINICAL UTILITY OF NEUT-X AND NEUT-Y IN THE DIAGNOSIS AND IDENTIFICATION OF SEPSIS |
SONAL YADAV |
| BHC-51 |
A |
09:20 AM - 09:30 AM |
UNLOCKING HOPE: UTILITY OF EMICIZUMAB IN ACQUIRED HEMOPHILIA |
VERONICA LOBO |
| BHC-55 |
A |
09:30 AM - 09:40 AM |
EXPERIENCE OF LOW DOSE FIRST LINE AND SECOND LINE ITI IN SEVERE HEMOPHILIA A PATIENTS WITH INHIBITORS FROM A SINGLE CENTRE IN INDIA |
BHARTI SAHNI |
| BHC-57 |
A |
09:40 AM - 09:50 AM |
HEMATOLOGICAL PROFILES IN GILBERT SYNDROME: INCREASED HEMOGLOBIN AND CARDIOMETABOLIC INSIGHTS |
MUGDHA GAUTAM |
| BHC-63 |
A |
09:50 AM - 10:00 AM |
ASSESSMENT OF RED CELL DISTRIBUTION WIDTH (RDW) AS PROGNOSTIC FACTOR IN CASE OF FEBRILE NEUTROPENIA |
SWEETY KUMARI |
| BHL-31 |
B |
09:00 AM - 09:10 AM |
AI-DRIVEN DIFFERENTIATION OF NRBCS, LYMPHOCYTES, AND BLAST CELLS FOR PRECISION IN HEMATOLOGICAL DISORDERS |
BUDDHADEV GOSWAMI |
| BHL-16 |
B |
09:10 AM - 09:20 AM |
REFERENCE INTERVAL FOR COAGULATION PARAMETERS IN NON-PREGNANT AND PREGNANT WOMEN. |
TRUPTI LADE |
| BHL-15 |
B |
09:20 AM - 09:30 AM |
UTILITY OF NEUTROPHIL LYMPHOCYTE RATIO (NLR) AND PLATELET LYMPHOCYTE RATIO (PLR) AS BIOMARKERS OF INFLAMMATION IN TYPE II DIABETES MELLITUS |
ADITYA HON |
| BHL-11 |
B |
09:30 AM - 09:40 AM |
BONE MARROW METASTASES IN SOLID NONHEMATOLOGICAL MALIGNANCIES AND RANK LIGAND (RANKL) EXPRESSION |
BAKIALAKSHMI V |
| BHL-6 |
B |
09:40 AM - 09:50 AM |
DONOR SPECIFIC ANTIBODIES IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANT : A RETROSPECTIVE STUDY |
POORNACHANDRAN V C |
| BHL-2 |
B |
09:50 AM - 10:00 AM |
HLA-DR EXPRESSION IN T CELL SUBSETS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
SHILPI SAXENA |
| MHC-41 |
C |
09:00 AM - 09:10 AM |
OCCAM'S RAZOR OR HICKAM'S DICTUM: MYELOID NEOPLASM WITH DISABLING MUSCULOSKELETAL PAIN |
SATYA NAMALA |
| MHC-42 |
C |
09:10 AM - 09:20 AM |
CLINICAL EXPERIENCE AND SHORT TERM OUTCOME OF AML AT A TERTIARY CARE CENTRE IN EASTERN INDIA. |
PRATIBHA SINGH |
| MHC-44 |
C |
09:20 AM - 09:30 AM |
OUTCOMES OF CHEMOIMMUNOTHERAPY IN TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A COMPREHENSIVE ANALYSIS |
RAJKIRAN EMMADI |
| MHC-47 |
C |
09:30 AM - 09:40 AM |
MOLECULAR PROFILE BY NEXT GENERATION SEQUENCING AND ITS IMPACT ON RISK STRATIFICATION AND OUTCOMES OF ACUTE MYELOID LEUKAEMIA - A TERTIARY CARE CENTRE EXPERIENCE FROM INDIA |
NITIN GUPTA |
| MHC-48 |
C |
09:40 AM - 09:50 AM |
A STUDY TO ANALYSE BONE HEALTH IN MULTIPLE MYELOMA PATIENTS USING RADIOLOGICAL AND BONE TURNOVER MARKERS |
UDAY YANAMANDRA |
| MHC-51 |
C |
09:50 AM - 10:00 AM |
AN AUDIT TO ASSESS SAFETY AND EFFICACY OF GENERIC DASATINIB IN CHRONIC MYELOID LEUKEMIA (CML) |
JYOTI CHIRMADE |
| MHL-19 |
D |
09:00 AM - 09:10 AM |
MINIMAL RESIDUAL DISEASE ASSESSMENT BY MULTIPARAMETER FLOW CYTOMETRY AND ITS ASSOCIATION WITH CYTOGENETIC ABNORMALITIES IN CASES OF MULTIPLE MYELOMA. |
GAURAV LALWANI |
| MHL-20 |
D |
09:10 AM - 09:20 AM |
MRD ASSESSMENT POST INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA : A TERTIARY CARE CENTER EXPERIENCE |
MEGALA CHANDRASEKAR |
| MHL-21 |
D |
09:20 AM - 09:30 AM |
STUDY OF IMMUNOPHENOTYPIC SIGNATURE OF ANTI-CD19 CART CELLS DURING INITIAL EXPANSION PHASE IN PAEDIATRIC BALL CASES RECEIVING CART THERAPY. |
DISHA JAIN |
| MHL-22 |
D |
09:30 AM - 09:40 AM |
EVALUATION OF MEASURABLE RESIDUAL DISEASE BY HIGH SENSITIVE MULTICOLOR FLOWCYTOMETRY IN A NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING INDUCTION THERAPY IN A TERTIARY CARE CENTER. |
SOUDAMINI MAHAPATRA |
| MHL-23 |
D |
09:40 AM - 09:50 AM |
BOMBR: A DEEP LEARNING APPROACH BASED DATASET FOR AUTOMATED RETICULIN FIBER DETECTION AND QUANTIFICATION IN BONE MARROW BIOPSIES |
SHAMBHAVI JHA |
| MHL-24 |
D |
09:50 AM - 10:00 AM |
INCIDENCE OF CYTOGENETIC ABNORMALITIES AND RECURRING MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA : A SINGLE CENTRE STUDY |
RESHMA BENSON |
